219 related articles for article (PubMed ID: 33991582)
1. Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions.
Pennington LF; Gasser P; Brigger D; Guntern P; Eggel A; Jardetzky TS
J Allergy Clin Immunol; 2021 Oct; 148(4):1049-1060. PubMed ID: 33991582
[TBL] [Abstract][Full Text] [Related]
2. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
[TBL] [Abstract][Full Text] [Related]
3. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
4. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
[TBL] [Abstract][Full Text] [Related]
6. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.
Kim B; Eggel A; Tarchevskaya SS; Vogel M; Prinz H; Jardetzky TS
Nature; 2012 Nov; 491(7425):613-7. PubMed ID: 23103871
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
[TBL] [Abstract][Full Text] [Related]
8. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
Gomez G
Front Immunol; 2019; 10():175. PubMed ID: 30792720
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites.
Platzer B; Baker K; Vera MP; Singer K; Panduro M; Lexmond WS; Turner D; Vargas SO; Kinet JP; Maurer D; Baron RM; Blumberg RS; Fiebiger E
Mucosal Immunol; 2015 May; 8(3):516-32. PubMed ID: 25227985
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IgE-mediated allergic reactions by pharmacologically targeting the circadian clock.
Nakamura Y; Nakano N; Ishimaru K; Ando N; Katoh R; Suzuki-Inoue K; Koyanagki S; Ogawa H; Okumura K; Shibata S; Nakao A
J Allergy Clin Immunol; 2016 Apr; 137(4):1226-1235. PubMed ID: 26559325
[TBL] [Abstract][Full Text] [Related]
11. Non-IgE-mediated anaphylaxis.
Cianferoni A
J Allergy Clin Immunol; 2021 Apr; 147(4):1123-1131. PubMed ID: 33832694
[TBL] [Abstract][Full Text] [Related]
12. An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis.
Zhou JS; Sandomenico A; Severino V; Burton OT; Darling A; Oettgen HC; Ruvo M
Mol Biosyst; 2013 Nov; 9(11):2853-9. PubMed ID: 24056872
[TBL] [Abstract][Full Text] [Related]
13. IgE knock-in mice suggest a role for high levels of IgE in basophil-mediated active systemic anaphylaxis.
Lübben W; Turqueti-Neves A; Okhrimenko A; Stöberl C; Schmidt V; Pfeffer K; Dehnert S; Wünsche S; Storsberg S; Paul S; Bauer S; Riethmüller G; Voehringer D; Yu P
Eur J Immunol; 2013 May; 43(5):1231-42. PubMed ID: 23423996
[TBL] [Abstract][Full Text] [Related]
14. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A
J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318
[TBL] [Abstract][Full Text] [Related]
15. CD23 provides a noninflammatory pathway for IgE-allergen complexes.
Engeroff P; Caviezel F; Mueller D; Thoms F; Bachmann MF; Vogel M
J Allergy Clin Immunol; 2020 Jan; 145(1):301-311.e4. PubMed ID: 31437490
[TBL] [Abstract][Full Text] [Related]
16. Rapid polyclonal desensitization with antibodies to IgE and FcεRIα.
Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Lewkowich I; Morris SC; Finkelman FD
J Allergy Clin Immunol; 2013 Jun; 131(6):1555-64. PubMed ID: 23632296
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions.
Fung-Leung WP; De Sousa-Hitzler J; Ishaque A; Zhou L; Pang J; Ngo K; Panakos JA; Chourmouzis E; Liu FT; Lau CY
J Exp Med; 1996 Jan; 183(1):49-56. PubMed ID: 8551243
[TBL] [Abstract][Full Text] [Related]
18. Rat monoclonal anti-murine IgE antibody removes IgE molecules already bound to mast cells or basophilic leukemia cells, resulting in the inhibition of systemic anaphylaxis and passive cutaneous anaphylaxis.
Miyajima H; Watanabe N; Ovary Z; Okumura K; Hirano T
Int Arch Allergy Immunol; 2002 May; 128(1):24-32. PubMed ID: 12037398
[TBL] [Abstract][Full Text] [Related]
19. Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.
Hong JY; Bae JH; Lee KE; Kim M; Kim MH; Kang HJ; Park EH; Yoo KS; Jeong SK; Kim KW; Kim KE; Sohn MH
Yonsei Med J; 2016 Nov; 57(6):1412-9. PubMed ID: 27593869
[TBL] [Abstract][Full Text] [Related]
20. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
